Clinical Trials for Recurrent Astrocytoma, IDH-Mutant

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT ID: NCT06860594

This clinical trial is studying a new approach to treat brain cancers called glioblastoma and astrocytoma, which have come back after initial treatment. The researchers want to see if adding a drug...